| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d6256baf554e46784d8daa478a2ddc6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
1981-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f95090bafc794025f1f845677c833b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935e30bcc4b2fabbe65c71f7ac0333c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d521ec24493349ef4ae51ef3fec0a1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_795b5afaf96f282cde24b40f3ed51c27 |
| publicationDate |
1982-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2492260-A1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COAGULATION FACTOR VIII |
| abstract |
THE INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING THE COAGULATION FACTOR VIII; A PHARMACEUTICAL COMPOSITION SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF HEMOPHILIA INCLUDING THE COAGULATION FACTOR VIII AND A PROTEASE INHIBITOR (IN PARTICULAR APROTININ) WHICH ARE INCORPORATED IN LIPOSOMES AND POTENTIALLY LYOPHILISED AND ENAPULATED. THE COMPOSITION ALLOWS TO OBTAIN A STRONG ABSORPTION OF THE COAGULATION FACTOR BY THE INTESTINAL PATHWAYS WITHOUT IT BEING DECOMPOSED IN THE GASTROINTESTINAL PATHWAYS EVEN BY ORAL ADMINISTRATION. |
| priorityDate |
1980-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |